NCT03769402 is a Phase 4 clinical trial of Citric acid in Intrabony Periodontal Defect, sponsored by Ain Shams University.

Who is sponsoring NCT03769402?

NCT03769402 is sponsored by Ain Shams University.

What drugs are being tested in NCT03769402?

Interventions in NCT03769402: Citric acid, Control Test.

What condition does NCT03769402 study?

NCT03769402 studies Intrabony Periodontal Defect.

Is NCT03769402 still recruiting?

NCT03769402 is currently completed. Last updated 7 December 2018.

Last reviewed 2018-12-07 · How we verify

NCT03769402

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Influence of Citric Acid Bone Surface Etching and Bone Defect Fill on GCF BMP-2 Release Profile

Completed Phase 4 Last updated 7 December 2018

What this trial tests

Phase 4 trial testing Citric acid in Intrabony Periodontal Defect in 20 participants. Completed in 1 November 2018.

Timeline

1 January 2016

Primary endpoint
1 May 2018

1 November 2018

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	1 January 2016
Primary completion	1 May 2018
Estimated completion	1 November 2018

Drugs / interventions tested

Citric acid (CITRIC ACID) — full drug profile →
Control Test — full drug profile →

Conditions studied

Intrabony Periodontal Defect — all drugs for Intrabony Periodontal Defect →

Sponsor

Ain Shams University

Who can join

Adults 20 to 60, any sex, with Intrabony Periodontal Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effect of citric acid on bone surface of infrabony defects when used for 30 seconds at ph 1 and 50% concentration before the application of bovine derived xenograft to fill the defect, Bone Morphogenic protein 2 (BMP-2) marker was evaluated in 5 different days during the first month after surgery and clinical and radiographic parameters were reassessed after 6 months

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Citric acid

Trials testing the same drug.

NCT03999203 — A Cross-sectional Study to Measure Cough in Severe Asthma · NA · completed
NCT02359942 — The Diagnostic Validity of the Urea Breath Test · NA · completed

Other recruiting trials for Intrabony Periodontal Defect

Currently open trials in the same condition.

NCT07146776 — Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts · NA · recruiting
NCT06768424 — Comparison of MIST With PRF and GBT With PRF in the Treatment of Intrabony Periodontal Defect. A Prospective RCT · NA · active not recruiting
NCT06058923 — MIST Versus M-MIST for the Treatment of Intrabony Defects · NA · active not recruiting
NCT05442034 — Rh-PDGF vs EMD for Treatment of Intra-bony Defects · Phase 1, PHASE2 · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03769402 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 7 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03769402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing